In a surprising turn of events, Robert F. Kennedy Jr., reportedly made significant changes within the Department of Health and Human Services (HHS), leading to the departure of two high-ranking officials.
Heather Flick Melanson, his Chief of Staff, and Hannah Anderson, Deputy Chief of Staff for Policy, are no longer part of the HHS team.
As reported by ABC News, the dismissals were abrupt and without any clear explanation. An anonymous source familiar with the situation told ABC that Kennedy "has every right to make personnel decisions." The HHS spokesperson confirmed the leadership change in a statement to ABC News, announcing that "Effective immediately, Matt Buckham will serve as Acting Chief of Staff."
Buckham, who has been serving as Kennedy's White House liaison at the HHS, will continue in this role while also taking on his new responsibilities as Acting Chief of Staff. The statement from HHS highlighted Buckham's "valuable experience in personnel strategy and organizational management."
It also expressed Kennedy's gratitude towards the outgoing leadership and his anticipation of working closely with Buckham as the Department continues its mission to "Make America Healthy Again."
This development at the HHS came in the wake of the FDA's controversial decision to grant full approval to Moderna's mRNA COVID-19 vaccine, Spikevax, for children as young as 6 months old through 11 years of age who are deemed "at increased risk" of COVID-19. This decision was made without Kennedy's authorization or briefing, raising questions about the internal dynamics within the HHS.
However, contrary to the initial reports, Gateway Pundit has learned that Heather Flick Melanson was not dismissed but resigned from her position. An insider source revealed that Melanson, a staunch supporter of President Trump, voluntarily left her post last week.
The FDA's full approval of the Moderna vaccine for children comes after its previous availability under Emergency Use Authorization (EUA). Despite growing evidence of adverse events, including myocarditis, pericarditis, allergic reactions, and seizures in young recipients, the FDA has greenlit the use of this experimental shot.
Dr. Robert Malone, a member of the Advisory Committee on Immunization Practices (ACIP), expressed his shock and disappointment at the FDA's decision, which he claims blindsided Kennedy. He clarified that contrary to the narrative on social media, Kennedy was not involved in the decision as he was on a working vacation at the time.
In his own words, "The narrative on MAHA Twitter after the FDA approved Moderna's SPIKEVAX vaccine for high-risk children is that this was a betrayal by Secretary Kennedy. But this is the OPPOSITE of what transpired. The Secretary was on vacation and not even briefed on the decision. It was a working vacation, and I have personal confirmation that he took many calls, briefings, and was constantly managing strategic and tactical decisions during his much-needed and well-earned vacation."
These recent events within the HHS and the FDA's decision to fully approve the Moderna vaccine for children have sparked a flurry of discussions and debates. As the situation continues to unfold, the focus remains on the health and safety of the American public, particularly the children who are now eligible for the vaccine.
Login